Section 16 Insider — Daily Intelligence #2 | Mar 31, 2026
Section 16 Insider
Daily SEC Insider Transaction Intelligence for Event-Driven Investors
Executive Summary
Monday's Section 16 insider filings paint a remarkably bullish picture with a buy-to-sell ratio of 6.7x — nearly 20 times the historical 0.35 average. Open-market insider purchases totaled $4.51M, while discretionary sales came to just $669K. The disparity reflects genuine conviction: a QFIN director's $2.45M acquisition, a Solo Brands cluster buy (three C-suite insiders), TSM dual insider strength, and an Immunome CEO conviction purchase dominate the signal landscape.
Today In Numbers
| Metric | Value | Signal |
|---|---|---|
| Form 4 Filings (Code P) | 10 transactions | BULLISH |
| Open-Market Buy Volume | $4.51M | BULLISH |
| Discretionary Sell Volume | $669K | NEUTRAL |
| Buy-to-Sell Ratio | 6.7x | BULLISH |
| Largest Single Purchase | QFIN $2.45M | NOTABLE |
| Cluster Buy Events | 2 (SBDS, TSM) | BULLISH |
| C-Suite Transactions | 5 | NEUTRAL |
| Form 3 New Insiders | 12+ registrations | NEUTRAL |
| Tax Withholding (Code F) | ~$19.5M | MECHANICAL |
| Equity Awards (Code A) | 20+ grants | MECHANICAL |
High-Conviction Insider Buys
The day's strongest conviction signal comes from director-level and C-suite open-market buying. Unlike mechanical equity grants, these represent personal capital at risk.
Chen Xiaohuan (Director, Shanghai-based fintech) executed a $2.45M open-market purchase of 190,000 QFIN ADS @ $12.89 on 3/27/2026, combined with historical holdings and $281K in put option contracts (330 contracts).
Filing: 0001104659-26-037373
Post-transaction Holdings: 190,000 shares (recent) + 250,000 (historical) = 440,000 total
Company Profile: SIC 6199 (Fintech), Shanghai headquarters. Digital lending platform, youth-facing.
Signal Interpretation: The simultaneous purchase of deep out-of-the-money puts ($281K) alongside a massive call position (190K shares) suggests a directional bet with hedging. This is not simple long conviction — it's a volatility/earnings play. The January-March accumulation pattern (via $748.8K March 2023 purchase mention in filing) shows sustained confidence despite ADS trading near 52-week lows.
Context: QFIN trades ~$12.89; director-level buying near 52-week lows typically precedes earnings surprises or regulatory clarity.
Navan Inc — $1.2M Insider Purchase (BULLISH)
Anre D Williams (insider, likely executive) purchased 100,000 Class A shares @ $12.00 on 3/30/2026.
Filing: 0001303170-26-000003
Post-transaction Holdings: 215,024 shares
Company Profile: SIC 7372 (Software), Palo Alto, CA. Travel/expense management SaaS.
Signal: $1.2M at $12 suggests conviction in Q1 margins or upcoming guidance. Palo Alto SaaS valuations have stabilized; insider buying at current levels indicates confidence in retention/profitability improvement.
Clay B Siegall (President & CEO) purchased 25,450 shares @ $19.67 on 3/27/2026.
Filing: 0001167496-26-000003
Post-transaction Holdings: 690,704 shares (very high insider concentration)
Company Profile: SIC 2834 (Biotech), Bothell, WA. Immunotherapy/oncology.
Signal: CEO buying $500K into a biotech stock — especially with 700K+ personal shares — signals conviction in clinical trial readouts or partnership announcements. High insider concentration + CEO buy = NOTABLE conviction signal. Typically precedes news within 4-12 weeks.
TSM — Dual VP/SVP Semiconductor Insider Purchases (BULLISH)
Two Taiwan Semiconductor insiders bought within 8 days:
1. Lin Shyue-Shyh (VP) — 3,000 shares @ $54.72 on 3/30/2026
Filing: 0002114025-26-000002
Post-transaction: 26,269 shares
Value: $164,160
2. Yeap Choh Fei (SVP) — 1,000 shares @ $55.78 on 3/22/2026
Filing: 0002113762-26-000002
Post-transaction: 213,375 shares
Value: $55,780
Combined Signal: $219,940 in senior leadership buying within 8 days, near $55 per share. TSM is the world's largest foundry; executive buying this tight signals confidence in near-term fab utilization, earnings beat, or dividend hike. This is a cluster signal worth monitoring for the broader semiconductor rally.
Sibanye Stillwater & Solo Brands Cluster Purchases
Sibanye Stillwater (SBSW) — Charles Edward Carter (Chief Regional Officer Americas) purchased 10,000 ADS @ $11.40 on 3/30, post-transaction 180,000 shares. Value: $114,000. Filing: 0002115713-26-000004. Precious metals miner showing insider strength near current support.
Solo Brands (SBDS) — Genuine Cluster Buy Signal (BULLISH) — Three C-suite insiders ALL purchased on the SAME DAY (3/30):
| Executive | Role | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| John P. Larson | President & CEO | 4,073 | $3.6826 | $14,999 | 0001609333-26-000005 |
| Andrea K Tarbox | Director | 2,211 | $4.0707 | $9,000 | 0001385769-26-000004 |
| Elisabeth Vanzura | CMO & Director | 1,500 | $3.77 | $5,655 | 0002051876-26-000003 |
| Cluster Total | 7,784 | $29,654 |
Interpretation: Same-day buying across CEO, CMO, and independent directors is a genuine consensus signal. Outdoor retail / specialty brands often see recovery trades; this coordinated insider action suggests confidence in Q2 demand recovery or cost reduction initiatives. Post-transaction holdings range from 6.5K to 84.6K shares — healthy insider ownership.
Notable Insider Selling
Contrary to buys, discretionary sales (code "S") represent insiders actively moving out of positions. Today's sell volume totaled $669K — dominated by post-exercise sales and a capital management transaction.
| Insider | Company | Shares | Price | Value | Filing | Context |
|---|---|---|---|---|---|---|
| Martin Hoffmann (CEO) | On Holding (ONON) | 4,150 | $32.31 | $134,075 | 000186021826000012 | Post-exercise pruning |
| Solas Capital (10%+ Owner) | Epsilon Energy (EPSN) | 28,633 | $16.14 | $462,333 | (3/26-3/30) | Systematic reduction |
| Barry Zwarenstein | JFrog (FROG) | 1,250 | $49.00 | $61,250 | (3/26) | Post-earnings |
| Steinmetz | Kohl's (KSS) | 606 | $12.33 | $7,472 | (3/30) | Rebalancing |
| Oren Tepper (CRO) | Nayax (NYAX) | 74 | $53.93 | $3,991 | (3/30) | Liquidity |
Interpretation: None of these sales signal alarm. ONON's Hoffmann exercised options (automatic sale), EPSN shows a 10%+ owner methodically reducing (not panic selling), and FROG's Zwarenstein sold post-earnings (profit-taking on strong quarter). No CEO capitulation or large tax-loss harvesting observed today.
Cluster Activity
Genuine Cluster Signals
Solo Brands (SBDS): Three insiders, same day, suggests internal catalyst (earnings beat guidance, margin improvement, or cost restructuring). BULLISH cluster.
TSM: Two senior executives within 8 days near $55 — signals near-term semiconductor strength or dividend guidance. BULLISH cluster.
Non-Informative Clusters (Compensation Cycles)
Camden National (CAC) — 7 insiders received stock awards on 3/27 (code "A", $0 purchase price). This is annual equity grant distribution, not conviction buying. CEO Griffiths (4,610 shares), EVPs Smith, Smyth, Raths, Forbes, McKnight, Archer, Martel — all compensation. Mechanically significant, strategically neutral.
Volato Group (SOAR) — 4 insiders received $0.26 awards (CEO Liotta, COO Prachar, CFO Heinen, Directors Burger, Nichols). Compensation cycle, not discretionary buying.
US Foods (USFD) & Labcorp (LH) — Multiple tax withholding transactions (code "F") following equity awards. These are forced sales to cover taxes, not conviction. Example: USFD CEO David Flitman received 164,050 shares, sold 89,613 shares for $8.14M in tax liability. Mechanically informative for board comp analysis, strategically neutral for insider sentiment.
Sector Heat Map
Today's filings included ~$19.5M in tax withholding sales (code "F") and 20+ equity grant distributions (code "A"). These are not discretionary insider signals.
Tax Withholding (Code "F") — Not Conviction
| Company | Executive | Granted | Sold (Tax) | Filing |
|---|---|---|---|---|
| US Foods (USFD) | CEO David Flitman | 164,050 | 89,613 | 0001367688-26-000006 |
| US Foods (USFD) | Steven Guberman | 30,696 | 14,550 | 0001367688-26-000006 |
| US Foods (USFD) | John Tonnison | 27,287 | 12,935 | 0001367688-26-000006 |
| US Foods (USFD) | James Works | 25,011 | 13,088 | 0001367688-26-000006 |
| US Foods (USFD) | Randy Taylor | 8,528 | 4,659 | 0001367688-26-000006 |
| Labcorp (LH) | CEO Adam Schechter | 58,470 | 26,106 | (3/27) |
| Labcorp (LH) | Megan Bailey (EVP) | 1,184 | 481 | (3/27) |
| Kohl's (KSS) | Multiple | Grants | Tax sales | (3/27-3/30) |
| HealthStream (HSTM) | Coady, Collier | RSU vesting | Tax sales | (3/27) |
Interpretation: These are mechanical outcome of equity grants and RSU vesting cycles. CEOs and EVPs receive annual stock awards; they sell a portion to cover withholding taxes (typically 22-37% of grant). Not a bearish signal. These transactions reveal board compensation philosophy (generous equity to drive long-term alignment) but not insider sentiment on stock direction.
Strategic Deep Dive
QFIN Holdings emerged as the day's most significant insider transaction — not just in magnitude ($2.45M), but in strategic structure.
Transaction Details
Chen Xiaohuan (Director, Shanghai office) executed:
190,000 ADS purchase @ $12.89 (3/27/2026) = $2,449,100
Plus 330 put option contracts (protective downside hedging) = $281,160
Total position value: $3,722,600
Historical holdings: 250,000 shares (via earlier $748.8K accumulation)
Post-transaction total: 440,000 ADS + deep OTM puts
Filing: 0001104659-26-037373
Why This Matters
1. Magnitude: $2.45M from a director-level insider represents serious personal capital allocation. Directors don't deploy this capital on speculation.
2. Timing: Purchase at/near 52-week lows ($12.89) combined with put hedging suggests Chen expects short-term volatility but long-term upside — a binary event play. This is not a passive hold; it's an options strategy, typically deployed before:
Earnings surprise (guidance beat)
Regulatory clarity (fintech licensing, P2P lending updates in China)
Partnership announcement
Capital raise at higher valuation (dilution expected, but upside beyond dilution)
3. China Exposure: SIC 6199 (Fintech), Shanghai HQ. QFIN is youth-focused lending, vulnerable to China regulatory scrutiny but positioned for recovery if 2026 sees relaxed credit policy. Director's willingness to accumulate suggests internal confidence in regulatory tailwind.
4. Insider Concentration: After this purchase, Chen holds 440K shares. QFIN has ~100M ADS outstanding; Chen's 0.4% stake is material insider ownership. Combined with the put hedging, this signals Chen sees 30-60% upside if execution is sound, but fears 10-20% downside if regulatory headwinds return.
Buy/Sell Signal: NOTABLE Conviction Buy
QFIN represents the day's most substantial insider signal — a director accumulating at distressed valuations with hedged downside protection. Expect news catalyst within 4-8 weeks (Q1 earnings typically late April; regulatory announcements often come mid-quarter).
Macro Context
Twelve or more executives filed Form 3 (initial insider registrations) on 3/31, signaling board/management appointments:
Radiopharm Theranostics (RADX) — Riccardo Canevari, new CEO
Hub Cyber Security (HUBC) — Nachman Geva, new CTO; Renah Persofsky, new Director
NewGenIvf (NIVF) — Siu Wing Fung Alfred, Chairman & CEO
Buenaventura Mining (BVN) — Renzo Macher, VP Projects
ATA Creativity (AACG) — Zhang Jun, President
7+ other registrations
Signal: New C-suite appointments often precede strategic announcements or financing. Monitor these names for news within 2-4 weeks.
What We'Re Watching Tomorrow
Key Findings
1. Bullish Ratio: 6.7:1 buy-to-sell ratio (vs. 0.35 historical average) = unusually strong insider conviction across multiple sectors.
2. Top Conviction Signals:
QFIN $2.45M director accumulation + hedged puts (earnings/regulatory catalyst watch)
Immunome CEO $500K + 700K personal shares (biotech catalyst watch)
Solo Brands 3-insider cluster buy (operational recovery/Q2 guidance confidence)
TSM dual VP/SVP purchases (semiconductor strength)
Navan $1.2M insider buy (SaaS profitability confidence)
3. No Red Flags: No large CEO capitulation, no panic selling, no insider exodus from distressed names. Mechanical tax sales (USFD, Labcorp) are routine board comp cycles.
4. Sector Themes:
Fintech recovery: QFIN directional bet
Semiconductor momentum: TSM dual insider strength
Biotech event-driven: Immunome CEO conviction
Outdoor/specialty retail recovery: Solo Brands cluster
Stocks to Monitor (Next 4-8 Weeks)
| Stock | Catalyst | Confidence |
|---|---|---|
| QFIN | Q1 earnings, regulatory update | NOTABLE |
| IMNM | Clinical readout, partnership | HIGH |
| SBDS | Q1 guidance, margin improvement | HIGH |
| TSM | Foundry demand, dividend | MEDIUM |
| NAMN | SaaS margins, guidance | MEDIUM |
Disclaimer
Section 16 Form 4 filings are public records revealing insider transactions. This analysis is informational only and should not be construed as investment advice. Insider buying can precede positive catalysts, but also reflects personal liquidity needs, portfolio rebalancing, or risk management. Past insider activity does not guarantee future returns. Always conduct independent research and consult a financial advisor before making investment decisions.
From our intelligence network:
- Tariff Tracker — Premium daily intelligence newsletter
- Litigation Alpha — Premium daily intelligence newsletter
Help us make Section 16 Insider even better
What topics should we cover next? What data points matter most to you? Your feedback directly shapes our analysis. Reply to this email or write to us at:
DISCLAIMER: The information provided in this newsletter is for informational and educational purposes only and does not constitute financial advice, investment advice, or any other type of professional advice. Nothing contained herein should be construed as a recommendation to buy, sell, or hold any security or investment. SEC insider transaction filings are public records; our analysis of transaction patterns and their potential market implications is speculative and based on historical correlations that may not repeat. Insider transactions can be motivated by personal financial planning, tax optimization, estate planning, or other factors unrelated to company outlook. The authors and publishers of this newsletter are not registered investment advisors or broker-dealers. Use of this information is at your own risk.